Transculturalizing Cardiometabolic Care: How Chile is Redefining Type 2 Diabetes Prevention Beyond Glycemic Control

SANTIAGO, CHILE — Traditional management models for type 2 diabetes (T2D) are facing a paradigm shift. A landmark consensus paper published by the Mechanick Transculturalization Research and Innovation ConSortium (METRICS)—led by Dr. Ramfis Nieto-Martínez in collaboration with Dr. Goodarz Danaei (Bernard Lown Scholar of the Harvard School of Public Health), Dr. Jeffrey I. Mechanick, Dr. Juan P. Gonzalez-Rivas, Dr. Carlos Grekin, and Dr. Diana de Oliveira-Gomes—outlines a bold new framework to combat the escalating cardiometabolic epidemic in Chile. By transculturalizing the Dysglycemia-Based Chronic Disease (DBCD) model, the consortium aims to move clinical practice away from late-stage glycemic management and toward early, culturally tailored preventive care.

Why It Matters: Overcoming Clinical Inertia

For decades, the global clinical response to diabetes has suffered from reactive, late-stage management. In Chile, where diabetes prevalence has reached 12.3% nationwide and up to 17.3% in urban elderly populations, patients often navigate a silent progression of insulin resistance and prediabetes for up to 15 years before receiving a formal diagnosis. By the time T2D is diagnosed, irreversible macrovascular and microvascular complications have frequently already set in.

The new consensus argues that clinical inertia during the «predisease» stage is a massive, missed opportunity. By treating prediabetes not as an isolated laboratory value, but as an actionable stage (Stage 2) of the broader DBCD continuum, healthcare providers can halt progression to cardiovascular disease (CVD) and overt diabetes without relying immediately on glucose-lowering pharmacotherapy.

The Breakthrough: The Transculturalized DBCD Model

The DBCD model conceptualizes dysglycemia as a progressive, four-stage continuum modulated by genetic predispositions, environmental exposures (the exposome), lifestyle behaviors, and social determinants of health (SDOH).

Stage 1: Risk Factors ──> Stage 2: Predisease ──> Stage 3: Disease ──> Stage 4: Complications
(Adiposity, Genetics)      (Prediabetes/IR)          (Overt T2D)          (CVD, Nephropathy)

To make this model clinically viable in Chile, the METRICS consortium utilized the Transcultural Diabetes Nutrition Algorithm (tDNA) protocol to adapt international clinical guidelines to the specific biological, socioeconomic, and cultural landscape of the Chilean population. This includes addressing distinct regional realities:

• Genetic Variations: High prevalence of the SLC16A11 risk allele in the Chilean population, which is independently associated with higher BMI and elevated insulin levels even in non-diabetic individuals.

• Ethnic Disparities: Marked differences in insulin resistance (HOMA-IR) and urbanization impact between indigenous Mapuche populations and those of European descent.

• Socioeconomic Gradients: A higher burden of obesity, shorter stature, and poor metabolic outcomes in women of lower socioeconomic status (SES).

• The Migrant Challenge: Integrating vulnerable migrant populations (such as Venezuelan and Haitian communities, who now comprise 8.8% of the Chilean population) into the national healthcare network (FONASA/CESFAM) regardless of their migratory status.

Key Strategies & Adapted Clinical Metrics

The consensus panel identified critical gaps in existing screening tools, noting that standard international guidelines fail to account for Latino-specific risk phenotypes. To optimize early detection and care, the panel compiled Chile-specific clinical adaptations:

Bridging the Gap: Implementation Tactics

Translating consensus into clinical practice requires actionable, community-oriented solutions. The METRICS panel proposed several high-impact tactics to implement these strategies across Chile’s hybrid healthcare system (FONASA/ISAPRES):

1. Transculturalized Lifestyle Medicine

• «Produce Prescriptions»: Allowing healthcare providers to prescribe fresh fruits and vegetables to low-income patients, redeemable via existing national infrastructures like the National Board of School Aid and Scholarships (JUNAEB).

• «Exercise is Medicine»: Standardizing exercise prescriptions tailored to patient demographics, utilizing local municipal spaces, and expanding school-based physical activity programs to combat the high rates of sedentariness (76% in young adults).

2. Digital Health (eHealth) & Telemedicine

• Social Network Screening: Deploying digital, automated versions of the validated LA-FINDRISC tool over social networks to screen large populations efficiently.

• Telecare Support: Integrating nurse-led telephone and eHealth monitoring to support lifestyle behavioral changes and prevent the deterioration of glycemic control (A1C) in primary care.

3. Patient-Centered Public Policy

• EHR Integration: Enhancing Electronic Health Records (EHR) to systematically collect and utilize clinical and SDOH data without increasing administrative burdens on clinicians.

• De-stigmatization: Training healthcare professionals to use non-stigmatizing, respectful language, as weight stigma has been shown to be a major psychological driver of elevated BMI.

Future Directions

The METRICS consensus provides a highly adaptable blueprint. The consortium’s next step is to launch clinical pilot programs within Chile’s Family Health Centers (CESFAM) to validate the cost-effectiveness of these early interventions. By demonstrating that early lifestyle-based DBCD management reduces long-term economic and clinical burdens, the authors hope to establish a template that can be transculturalized to other diverse populations globally.

Reference

Nieto-Martinez R, Grekin C, De Oliveira-Gomes D, Gonzalez-Rivas JP, Lopez-Arana S, Mechanick JI. Consensus Conference Series on Dysglycemia-Based Chronic Disease (DBCD) in Latin America: The Chilean Transculturalization. Annals of Global Health. 2026; 92(1): 65, 1-22. DOI: https://doi.org/10.5334/aogh.5370